Abstract Body

Background

Identifying the mechanisms contributing to the persistence of HIV reservoirs during antiretroviral therapy (ART) is essential to the development of strategies aimed at eradicating them. Since senescent T cells accumulate with age and infection, we hypothesized that the HIV reservoir may preferentially persist in these cells after prolonged ART. 

Methods

We used a modified version of the HIV-Flow assay to analyze the phenotype of cells harboring inducible proviruses (p24+ cells) in blood samples from 9 participants who maintained undetectable plasma viral loads for 3-24 years. CD4+ T cells were stimulated for 24h with anti-CD3 and anti-CD28 antibodies, and cellular markers that are associated with T cell senescence were measured. CD4+ T cells from the same participants were treated with the senolytic drugs quercetin and fisetin, and HIV DNA was measured by qPCR at 24h post-treatment. In addition, we used HIV-Flow to measure the number of p24+ cells 24h after senolytic treatment and stimulation with PMA/ionomycin.

Results

We observed a 37-fold enrichment of p24+ cells in discrete subsets of effector memory cells expressing KLRG1, granzymes A or B, and TNFa or IFNg (p=0.007). Overall, a relatively large proportion of p24+ cells displayed this senescent-like phenotype (57% compared to 2% in the general CD4+ T cell population). We also evaluated the effect of senolytic drugs on the survival of these cells ex vivo. CD4+ T cells treated with 15mM quercetin or 15mM fisetin displayed a significant reduction in the frequency of p24+ cells/million CD4+ T cells following reactivation (1.84-fold and 30-fold decreases respectively, p=0.02 for both). Frequencies of p24+ cells were rescued by pre-treating the cells with the apoptosis inhibitor Q-VD-Oph, indicating that the drugs induced the death of p24+ cells rather than the inhibition of proviral reactivation. In parallel, cells were treated similarly and integrated HIV DNA was quantified. Both quercetin and fisetin led to a significant reduction in the levels of integrated HIV DNA (3.0-fold decrease, p=0.005 and 3.8-fold decrease, p=0.002 respectively). 

Conclusions

Our data show a marked enrichment of cells with inducible and translation competent HIV genomes in the CD4 senescent-like compartment, which likely contributes to their persistence during ART. The senolytic drugs quercetin and fisetin significantly reduced the pool of cells harboring integrated HIV genomes, including the translation-competent reservoir.